Peter Switzer talks with Propell (PHL) CEO, Michael Davidson

Dr Ross explores a new treatment for high blood pressure, a quad pill that contains four low dosages of a blood pressure pill in one.

Peter Switzer talks with Vectus Biosystems (VBS) CEO, Maurie Stang.

Peter Switzer is joined by Marcus Bogdan of Blackmore Capital, Senior Economist at AMP, Diana Mousina, CEO of EMvision Ron Weinberger, and property expert Chris Gray.

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Peter Switzer is joined by Michael Wayne of Medallion Financial Group, Julia Lee of Burman Invest, and Jun Bei Liu of Tribeca Investment Partners.

Dr Ross cracks down on whether our bodies really need 10,000 steps a day. Is it fact or just a myth?

Peter Switzer is joined by Michael Gable of Fairmont Equities, Paul Rickard from the Switzer Report, founder of Propertyology Simon Pressley, and senior economist at REA Group, Eleanor Creagh.

Peter Switzer and Paul Rickard share their thoughts on major current affairs impacting financial markets and the economy.

Peter Switzer is joined by Julia Lee of Burman Invest, portfolio manager at Coolabah Capital, Chris Joye, and Adam Dawes of Shaw & Partners.

Several studies conducted show that having a couple of cups of coffee a day, can lower the rates of certain diseases and illnesses.

Peter Switzer assesses whether the stock market is headed for a crash, and is joined by Shane Oliver of AMP Capital, chief economist at Ray White, Nerida Conisbee, and Paul Rickard from the Switzer Report.